Abstract
Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-48310-4, published online 14 May 2024 In the version of the article initially published, there were numerical errors in the Supplementary Data where some overall survival times were missing and where reported progression-free survival times eclipsed overall survival time. The overall survival times have been updated and based on the durable clinical benefit criteria of immunotherapy (complete response, partial response or stable disease with PFS > 6 months or OS > 1 year), three patients with stable disease (SMC__Pat50, SMC__Pat118, and SMC__Pat239) have been reclassified as responders. Figures 5 and 6, Supplementary Fig. 20, Supplementary Data 8 and Source Data 19b have now been updated. Despite this reclassification, there were no significant changes in the cell state terms in Figs. 5e, 6e and Supplementary Fig. 20a. For comparison, the original figures are available in the Supplementary Information accompanying this amendment. The changes are made in the HTML and PDF versions of the article.
| Original language | English |
|---|---|
| Article number | 2806 |
| Journal | Nature Communications |
| Volume | 16 |
| Issue number | 1 |
| DOIs |
|
| State | Published - Dec 2025 |